Hikal Limited

NSE: HIKAL BSE: 524735 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

221 3(1%)

Volume

3L as on 24, Dec

Open

367

High

376

Low

366

218

VWAP

374

52 Week High

457

52 Week Low

146

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,725

No. of Shares

12.3

P/E

64.82

P/B

4.01

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

6.18

ROCE

Profit Growth

Listing Date

14-Feb-01

Promoter Holding

68.85%

FII Holding

2.31%

DII Holding

7.05%

Price Chart

Price Performance

1 Week8%

1 Month4%

3 Months3%

6 Months3%

1 Year3%

YTD3%

Moving Average

5 Day SMA382

10 Day SMA398

20 Day SMA411

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	392	371	386	390
Resistance 2	386	369	380	385
Resistance 1	376	368	376	375
Pivot Point	371	366	371	370
Support 1	361	365	365	359
Support 2	355	363	361	354
Support 3	345	362	355	344

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.82%	(0.01) 68.77%	(0.01) 68.77%	(0.01) 68.77%	(0.01) 68.77%	(0.01) 68.77%
FIIs	(-1.91) 2.31%	(-1.11) 4.23%	(-0.41) 5.35%	(-0.41) 5.70%	(-0.71) 6.06%	(0.11) 6.78%	(0.11) 6.66%	(0.41) 6.55%	(1.31) 6.14%	(0.21) 4.81%	(0.01) 4.57%	(0.21) 4.56%	(0.11) 4.40%	(0.41) 4.27%	(-3.01) 3.91%	(0.01) 6.92%	(0.61) 6.91%	(0.01) 6.36%
DIIs	(1.91) 7.05%	(1.11) 5.15%	(0.21) 4.03%	(0.31) 3.80%	(-0.11) 3.48%	(0.41) 3.58%	(-0.41) 3.17%	(0.41) 3.53%	(0.01) 3.15%	(0.31) 3.11%	(0.61) 2.78%	(0.61) 2.18%	(0.21) 1.57%	(0.51) 1.37%	(0.01) 0.89%	(0.51) 0.89%	(-0.21) 0.39%	(0.01) 0.59%
Public	21.78%	21.75%	21.76%	21.65%	21.61%	20.79%	21.32%	21.06%	21.85%	23.22%	23.79%	24.40%	25.20%	25.58%	26.43%	23.42%	23.93%	24.28%
No. of Shareholders	74,117	73,404	71,391	68,907	71,801	71,912	70,978	71,840	74,657	76,126	75,110	75,167	75,780	78,500	79,105	75,341	72,450	68,233

Quarterly Results

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	494.3	318.5	380.4	552.4	447.7	452.9	406.8	514.1	447.5	434.88	388	545.29	540.2	559	379	502	515	469	456.78
Expenses	411.6	311.3	355.3	429	375.6	378	348.8	419.7	382.8	377.36	337.7	457.28	465.62	489	356	441	422	378	361.02
Operating Profit	82.7	7.2	25.1	123.4	72.1	74.9	58	94.4	64.7	57.52	50.3	88.01	74.58	70	23	61	93	91	95.76
OPM %	16.73	2.26	6.6	22.34	16.1	16.54	14.26	18.36	14.46	13.23	12.96	16.14	13.81	12	6	12	18	19	20.96
Other Income	-35.2	1.9	1	0.5	3.6	0.4	0.5	0.5	0.1	0.99	0.9	0.38	2.51	1	3	0	1	1	3.18
Interest	15.5	14.9	17.1	17.9	18.7	18.8	19.8	15.3	14.2	13.08	13.8	12.98	13.03	11	11	8	7	8	7.99
Depreciation	41.2	41.2	39.4	37.7	33.2	31.7	31.8	32.3	29	28.57	27.7	26.83	28.27	27	26	24	25	24	22.56
Profit before tax	-9.2	-47	-30.4	68.3	23.8	24.8	6.9	47.3	21.6	16.86	9.7	48.58	35.79	33	-12	29	62	60	68.39
Tax %	-35.87	-25.74	-26.32	26.5	27.73	26.21	26.09	28.33	25.46	25.44	28.87	25.9	26.21	24	-25	28	27	26	26.1
Net Profit	-5.9	-34.9	-22.4	50.2	17.2	18.3	5.1	33.9	16.1	12.57	6.9	36	26.41	25	-9	21	45	44	50.54
EPS in Rs	-0.48	-2.83	-1.82	4.07	1.39	1.48	0.41	2.75	1.31	1.02	0.56	2.92	2.14	2.01	-0.72	1.68	3.67	3.57	4.1

Profit and Loss

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1860	1785	2023	1943	1720	1507	1590	1296	1014	926	872	829	660
Expenses	1531	1518	1765	1602	1398	1234	1291	1054	813	745	689	642	476
Operating Profit	328	267	258	341	323	273	298	242	201	181	182	187	184
OPM %	18	15	13	18	19	18	19	19	20	20	21	23	28
Other Income	5	2	5	5	5	-12	2	4	-3	2	2	34	-42
Interest	75	56	48	31	36	52	58	49	48	62	60	68	60
Depreciation	134	118	109	96	85	82	93	86	69	67	64	55	49
Profit before tax	124	96	105	219	206	127	149	112	80	53	60	98	33
Tax %	27	27	26	27	36	33	31	31	16	23	32	35	24
Net Profit	91	70	78	160	133	84	103	77	68	41	40	64	25
EPS in Rs	7.36	5.64	6.36	13.02	10.8	6.85	8.36	6.26	5.49	3.34	3.28	5.17	2.04
Dividend Payout %	11	21	19	12	19	18	14	13	15	20	20	12	16

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	280	187	315	294	229	285	186	139	163	186	102	154	61
Cash from Investing Activity	-136	-174	-292	-284	-156	-164	-125	-110	-102	-64	-43	-23	-28
Cash from Financing Activity	-144	-27	-8	-6	-97	-101	-55	-25	-63	-124	-69	-124	-27
Net Cash Flow	0	-14	15	4	-24	20	6	4	-2	-2	-10	7	6

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	25	25	25	25	25	25	25	25	25	16	16	16	16	16	16
Reserves	1170	1238	1179	1163	1109	1043	909	792	732	653	589	547	516	488	434
Borrowings	683	765	775	818	748	675	610	646	661	635	598	505	547	546	584
Other Liabilities	472	502	482	482	504	470	370	306	268	237	177	206	212	219	157
Total Liabilities	2349	2529	2460	2487	2385	2213	1913	1768	1686	1542	1379	1275	1292	1270	1191
Fixed Assets	1340	1364	1038	1071	948	879	713	735	713	634	668	623	639	644	660
CWIP	134	121	438	414	412	295	254	161	79	118	63	66	62	61	49
Investments	10	10	17	5	5	11	1	1	1	3	4	3	3	3	3
Other Assets	865	1034	967	997	1020	1028	946	871	893	788	645	583	588	562	479
Total Assets	2349	2529	2460	2487	2385	2213	1913	1768	1686	1542	1379	1275	1292	1270	1191

Delivery

#	Date	146 56% 228	Value (Cr)	Q/T 67	Del 47	Del 6
1	27-May	221	23	80	40	9
2	26-May	218	12	71	50	6
3	25-May	214	9	72	58	5
4	22-May	205	2	35	48	1
5	21-May	206	4	43	41	2
6	20-May	205	4	37	51	2
7	19-May	204	4	29	39	2
8	18-May	196	3	30	50	2
9	15-May	201	3	41	49	2
10	14-May	209	7	38	43	3
11	13-May	202	4	36	39	1
12	12-May	199	5	48	42	2
13	11-May	209	6	63	35	2
14	8-May	211	7	62	43	3
15	7-May	213	10	47	49	5
16	6-May	211	29	85	35	10
17	5-May	197	6	70	47	3
18	4-May	195	5	46	56	3
19	30-Apr	189	4	60	42	2
20	29-Apr	189	7	89	41	3
21	28-Apr	188	3	64	49	1
22	27-Apr	189	4	66	51	2
23	24-Apr	181	5	64	46	2
24	23-Apr	187	4	47	50	2
25	22-Apr	189	3	61	50	1
26	21-Apr	188	3	41	52	2
27	20-Apr	188	8	105	59	5
28	17-Apr	192	6	78	49	3
29	16-Apr	188	4	47	42	1
30	15-Apr	188	5	70	46	2
31	13-Apr	183	5	46	38	2
32	10-Apr	180	7	62	45	3
33	9-Apr	175	5	58	42	2
34	8-Apr	175	7	96	45	3
35	7-Apr	165	9	73	39	4
36	6-Apr	163	4	50	42	2
37	2-Apr	161	5	59	37	2
38	1-Apr	160	7	70	38	3
39	30-Mar	147	9	75	45	4
40	27-Mar	156	14	90	54	7
41	25-Mar	165	8	63	52	4
42	24-Mar	162	8	53	47	4
43	23-Mar	157	9	63	45	4
44	20-Mar	168	6	62	35	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
28-May	2,725c	19c	0.67
27-May	2,743c	70c	2.62
26-May	2,673c	22c	0.84
25-May	2,651c	95c	3.70
22-May	2,556c	37c	1.45
21-May	2,520c	9c	0.37
20-May	2,510c	16c	0.64
19-May	2,494c	77c	3.18
18-May	2,417c	91c	3.61
15-May	2,508c	69c	2.68
14-May	2,577c	113c	4.58
12-May	2,464c	124c	4.79
11-May	2,588c	38c	1.46
07-May	2,626c	19c	0.72
06-May	2,608c	207c	8.60
05-May	2,401c	53c	2.24
04-May	2,348c	22c	0.95
30-Apr	2,326c	9c	0.36
29-Apr	2,335c	26c	1.14
28-Apr	2,308c	89c	4.02
24-Apr	2,219c	118c	5.03
23-Apr	2,337c	4c	0.17
22-Apr	2,333c	27c	1.18
21-Apr	2,306c	60c	2.55
17-Apr	2,366c	68c	2.95
16-Apr	2,298c	20c	0.87
15-Apr	2,318c	0	0

Stock Checklist

Price is below from 52 week high low average: 52%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView